“…Cell entry of HPV16 is facilitated by a clathrin-, caveolinand dynamin-independent but tetraspanin-and actindependent endocytosis pathway (Spoden et al, 2008;2013;Schelhaas et al, 2012;Scheffer et al, 2013). After cell entry, intracellular trafficking through endosomal and Golgi compartments leads to capsid disassembly and release of the L2/HPV genome complex (Bienkowska-Haba et al, 2009b;Cerqueira and Schelhaas, 2012;Florin et al, 2012;Day et al, 2013;Lipovsky et al, 2013;Sapp, 2013). The minor capsid protein L2 chaperones the viral genome into the nucleus and accumulates at subnuclear foci, the PML nuclear bodies (PML-NBs) (Day et al, 1998;Florin et al, 2002a) leading to manifestation of infection, stimulation of cell proliferation, vegetative amplification of the genome, and, finally, viral morphogenesis (Chiang et al, 1992;Florin et al, 2002a;Becker et al, 2004;Day et al, 2004;Doorbar, 2005;Munger et al, 2006;Graham, 2008;Schwartz, 2008).…”